Vesicular Glutamate Transporter (Vglut) Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Vesicular Glutamate Transporter (VGLUT) neurons represent the primary excitatory neuronal population in the central nervous system (CNS). These neurons are characterized by their expression of vesicular glutamate transporters (VGLUTs), which are responsible for packaging glutamate into synaptic vesicles for Ca²⁺-dependent release at glutamatergic synapses. VGLUT-expressing neurons constitute the vast majority of excitatory synapses in the brain and are essential for fast synaptic transmission, synaptic plasticity, and higher cognitive functions. [1]
Three VGLUT isoforms have been identified in mammals: [2]
VGLUTs are proton-coupled antiporter proteins that utilize the proton gradient generated by the V-ATPase to drive glutamate uptake into synaptic vesicles. Each VGLUT molecule transports approximately 2 glutamate molecules per proton symported. The transport cycle involves: [3]
VGLUT expression is tightly regulated during development and in response to neuronal activity. Key transcription factors include: [4]
VGLUT neurons are distributed throughout the CNS with region-specific expression patterns: [5]
| Brain Region | Primary VGLUT | Function | [6]
|--------------|---------------|----------| [7]
| Cerebral Cortex | VGLUT1, VGLUT2 | Corticocortical excitation |
| Hippocampus | VGLUT1 | Schaffer collateral, perforant path |
| Thalamus | VGLUT2 | Sensory relay |
| Cerebellum | VGLUT2 | Mossy fiber input |
| Brainstem | VGLUT2, VGLUT3 | Sensory processing |
| Basal Ganglia | VGLUT2 | Direct/indirect pathways |
VGLUT neurons form excitatory synapses onto both excitatory and inhibitory neuronal populations. The postsynaptic targets express ionotropic glutamate receptors (AMPA, Kainate, NMDA) and metabotropic glutamate receptors (mGluR1-8). This arrangement enables:
VGLUT neurons utilize a classic vesicular release mechanism:
Postsynaptic glutamate receptors on VGLUT neuron targets:
Ionotropic Receptors:
Metabotropic Receptors (Group I-III):
Excessive glutamate release from VGLUT neurons or impaired clearance leads to excitotoxic cell death — a central mechanism in many neurodegenerative disorders:
Mechanism:
VGLUT dysfunction contributes to AD pathogenesis through several mechanisms:
References: Bayer et al., VGLUT in AD (2020), Palop et al., Network dysfunction in AD (2011)
VGLUT neurons in the basal ganglia are affected in PD:
References: Parent & Hazrati, Functional anatomy of basal ganglia (1995), Picconi et al., Striatal synaptic plasticity in PD (2012)
VGLUT alterations in ALS:
References: Benkler et al., VGLUT and ALS (2010), Van Den Bosch et al., ALS excitatory dysfunction (2006)
VGLUT dysregulation is a hallmark of epileptogenesis:
| Target | Drug | Stage |
|---|---|---|
| NMDA receptors | Memantine | Approved (AD) |
| AMPA receptors | Perampanel | Approved (Epilepsy) |
| mGluR2/3 | LY341495 | Clinical trials |
| Vesicular release | Riluzole | Approved (ALS) |
| Glutamate transport | Ceftriaxone | Clinical trials |
The discovery of VGLUTs revolutionized understanding of glutamatergic transmission:
The study of Vesicular Glutamate Transporter (Vglut) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Shigeri et al. Molecular pharmacology of glutamate transporters (2004). 2004. ↩︎
Bayer et al. VGLUT alterations in Alzheimer's disease (2020). 2020. ↩︎
Palop et al. Network hyperexcitability and amyloid-beta in Alzheimer's disease (2011). 2011. ↩︎
Van Den Bosch et al. The role of excitotoxicity in ALS (2006). 2006. ↩︎
Takamori et al. Structure and function of vesicular glutamate transporters (2006). 2006. ↩︎
Bellocchio et al. Up-regulation of VGLUT1 in the cerebral cortex of Parkinson's disease (2000). 2000. ↩︎
El Mestikawy et al. VGLUT3: a third vesicular glutamate transporter (2011). 2011. ↩︎